These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19210710)

  • 1. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients.
    Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
    J Sex Med; 2009 May; 6(5):1248-58. PubMed ID: 19210710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance.
    Ljunggren C; Hedelin H; Salomonsson K; Ströberg P
    J Sex Med; 2008 Feb; 5(2):469-75. PubMed ID: 18086159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction.
    Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
    J Sex Med; 2009 Dec; 6(12):3449-57. PubMed ID: 19686427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.
    Rubio-Aurioles E; Porst H; Eardley I; Goldstein I
    J Sex Med; 2006 Nov; 3(6):1037-1049. PubMed ID: 17100937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
    J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury.
    Giuliano F; Rubio-Aurioles E; Kennelly M; Montorsi F; Kim ED; Finkbeiner AE; Pommerville PJ; Colopy MW; Wachs BH;
    Spine (Phila Pa 1976); 2008 Apr; 33(7):709-15. PubMed ID: 18379396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partners.
    Edwards D; Hackett G; Collins O; Curram J
    J Sex Med; 2006 Nov; 3(6):1028-1036. PubMed ID: 17100936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients.
    Schmid DM; Schurch B; Hauri D
    Eur Urol; 2000 Aug; 38(2):184-93. PubMed ID: 10895011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction.
    Rosen R; Broderick G; Shabsigh R; Swindle R; Lockhart D; Cameron A
    J Sex Med; 2005 Jul; 2(4):461-8. PubMed ID: 16422840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.